Featured Articles

Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

By August 17, 2020August 19th, 2024No Comments

Featured Article

Featured Article

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, and external stimuli. Because PIH is a common condition that has a substantial effect on the quality of life, an understanding of its treatment modalities is essential. Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies focus on PIH. This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Read more

This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Adele Shenoy BA, Raman Madan MD

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, secondary to inflammatory skin conditions such as acne, atopic dermatitis, contact dermatitis, and psoriasis, as well as external factors such as burns and radiation therapy. An understanding of treatment strategies for PIH is essential, as it has a large impact on the quality of life.

Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies specifically address PIH. Thus, we conducted a literature review on PubMed using key words “post-inflammatory hyperpigmentation” OR “postinflammatory hyperpigmentation.”

Studies that did not specifically address PIH and articles that were not published in English were excluded. Additional studies were obtained by scanning references. This review adds to the current literature by discussing the evidence for topical therapies, chemical peels, and laser therapy used specifically for hyperpigmentation from PIH.

Read Full Article Now
Article Cited in this Post

Inclusive Derm Atlas PIH Images

You May Also Like

Journal of Drugs in Dermatology JDD Article about Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis

| Derm Community, Featured Articles, Latest News | No Comments
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…

Year in Review: 2025 Highlights From JDD

| Featured Articles, Latest News | No Comments
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability From the Editor-in-Chief Dear Readers, As we look back on 2025, one…

Impact of Low-Dose Oral Minocycline (DFD-29) on Skin, Gastrointestinal, and Vaginal Microflora in Healthy Adults

| Featured Articles, Latest News, Rosacea, Women | No Comments
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…

Leave a Reply